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It has been known for over half a century that homocysteine levels are elevated in liver cirrhosis, but the basis for it is not fully
understood. Using differential display, we identified betaine homocysteine methyltransferase (BHMT) as a gene down-regulated in rat liver
cirrhosis and most likely involved in this dysregulation. A partial BHMT clone was isolated by screening of a cDNA library with the
differential display fragment. The full-length gene was generated by primer extension of cDNA. Expression levels of BHMT in cirrhotic
livers of bile duct ligated rats were compared to controls by Northern and Western blotting as well as by enzyme activity measurements.
BHMT mRNA levels were reduced to 29F 23% in established liver cirrhosis induced by bile duct ligation (BDL) as compared to controls.
Enzyme assays in crude liver homogenates showed a similar reduction in BHMT activity in bile duct ligated rat livers. By Western blotting,
BHMT could be detected in crude liver homogenates of control animals, but was reduced to below the limit of detection in cirrhotic livers. In
conclusion, these findings establish a reduced BHMT enzyme activity in cirrhotic rat livers, which may explain the elevated plasma
homocysteine levels in cirrhosis.D 2003 Elsevier Science B.V. All rights reserved.Keywords: Gene regulation; Betaine homocysteine methyltransferase; Expression; Differential display1. Introduction
Cirrhosis of the liver is among the most frequent diseases
in Western countries. The prognosis for patients with liver
cirrhosis is unfavorable because of the multiple complica-
tions these individuals may develop. Although the liver has
a remarkable capacity for regeneration, this potential is
largely impaired or even lost in liver cirrhosis. This is due
to a cascade of events leading to loss of acinar structure,
increased connective tissue content, and progressive loss of
liver function which occurs when the liver is repeatedly
challenged by intoxication with alcohol or by infection with
hepatitis C virus. In the end-stage of cirrhosis, the failure of
the liver to regenerate properly leads to hepatic decompen-
sation and death.0925-4439/03/$ - see front matter D 2003 Elsevier Science B.V. All rights reserv
doi:10.1016/S0925-4439(03)00037-1
Abbreviations: BHMT, betaine homocysteine methyltransferase; BDL,
bile duct ligation; RACE, rapid amplification of cDNA ends; GAPDH,
glyceraldehyde-3-phoshpate dehydrogenase
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tortion of the liver cell plates, proliferation of bile ducts,
sinusoidal capillarization, and fibrosis of the portal triads.
The signals triggering cirrhogenesis and regeneration are
largely unknown. Knowledge of primary signals that upset
the maintenance of proper liver function and regeneration or
trigger necrosis or apoptosis will be extremely valuable in
understanding the cause of liver cirrhosis and in working
towards its treatment. We have previously demonstrated that
mRNA differential display [1] is useful in exploring changes
that occur at the gene expression level in liver cirrhosis [2].
Cirrhosis induced by bile duct ligation (BDL) in the rat is a
well-established model and has been characterized to a great
extent [3,4]. We here used differential display [5] to identify
betaine homocysteine methyltransferase (BHMT) as an
enzyme down-regulated in rat liver cirrhosis. Cloning of the
rat BHMT gene revealed a predicted gene product with 92%
identity to human BHMT isoform 1 [6]. BHMT mRNA and
protein levels were strongly reduced in the livers of bile duct
ligated rats as compared to sham operated controls. Direct
enzyme activity measurements corroborated the impaired
remethylation of homocysteine by BHMT in cirrhotic rated.
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BHMT activity is a contributing factor to the elevated serum
homocysteine levels observed in liver cirrhosis.2. Materials and methods
2.1. Materials
Klenow DNA Polymerase, DIG Easy Hyb, and Nylon
membranes were purchased from Roche. The random
primed DNA labeling kit was bought from United States
Biological. Nucleotides were from Gibco BRL, [32P]dCTP
from Amersham and 3H-dimethylsulfate from American
Radiochemicals. Other chemicals were supplied by Merck
or Sigma and were of analytical grade.
2.2. Induction of cirrhosis
Male Sprague–Dawley rats were kept on a 12-h light–
dark cycle on a standard diet ad libitum. Biliary cirrhosis
was induced by BDL and excision of the bile duct as
described [7] and as modified [8]. Plasma bile acid concen-
trations were 46F 10, 40F 7, and 78F 16 AM after 7, 14,
and 28 days of BDL, respectively. Sham operated control
animals had plasma bile acid concentrations of 0.8F 3 AM.
Other parameters were also assessed, such as bilirubin, liver,
spleen, and body weight, liver histology, etc. (not shown).
All parameters were within the ranges observed by many
others for bile duct ligated rats. BDL animals were sacri-
ficed 7, 14, and 28 days after surgery. Control animals were
sham operated. In all groups, 2 g of liver mass was
homogenized immediately in guanidinium-isothiocyanate
buffer for mRNA isolation as described [9].
2.3. cDNA library screening
A rat liver cDNA library comprising 3.5 105 independ-
ent primary transformants in Escherichia coli WM1100 was
kindly provided by Dr. B. Hagenbuch [10]. Clones were
plated on agar plates of 15 25 cm at a density of 20 to
40000 colonies per plate. Colony lifts were prepared essen-
tially as described [11] and hybridized with probe F18,
derived from differential display experiments conducted
with normal and 28-day cirrhotic livers as described pre-
viously [2]. Positive clones were subcloned on standard
petri dishes and re-screened with the same probe. The
resulting partial BHMT clones were saved as clones
pMF1.103 and pMF1.114 and checked for identity with
fragment F18 in the 3V-end region by partial sequencing.
2.4. DNA sequencing
Plasmid DNA of clone pMF1.103 was isolated by CsCl
density gradient centrifugation and sequenced on both
strands by primer walking using a kit from AmershamPharmacia Biotech. In a later stage, sequencing was per-
formed by a commercial service (Microsynth GmbH, Bal-
gach, Switzerland) using selected primers designed by the
authors. Using further sequence data from the RACE clones
(see below), a full-length fragment assembly was carried out
using the software from the Wisconsin Genetics Computer
Group. The DNA sequence has been deposited in GenBank
(accession no. U96133).
2.5. Cloning of 5V-end
Primer RA6 (5V-GAC TCA CAC CTC CTG CAA CC-3V),
based on the partial BHMT gene sequence of clone
pMF1.103, was used to elongate and amplify the 5V-end of
BHMT mRNA by rapid amplification of cDNA ends
(RACE), using the MARATHON-Kit (Clontech) according
to the protocol of the manufacturer. Products were blunt-end
ligated into pGEM3Zf- (Promega). Competent E. coli
DH5a or JM109 cells were transformed with the ligated
DNA and plasmid DNA was isolated from transformed
clones as described [12].
2.6. Northern blots
Total RNA of rat livers was prepared as described [9] and
glycogen was removed by precipitation with 2 volumes of
4.5 M sodium acetate, pH 7, at  20 jC overnight. The
RNA was pelleted by centrifugation for 30 min at
10,000 g, suspended in 10 mM Tris–Cl, pH 7.5, 1 mM
EDTA, 0.5% sodium dodecylsulfate, and extracted with
phenol and chloroform by published methods [12]. RNA
was precipitated for storage at  20 jC by adding 1/10
volume of 2 M sodium acetate, pH 5.5, and 9 volumes of
isopropanol. For blotting, 10 Ag of total RNA was electro-
phoresed on a 1.2% agarose gel containing 6.6% form-
aldehyde [13]. The RNA was transferred to nylon
membranes by electroblotting and fixed by UV irradiation
and baking. Hybridization was performed with DIG Easy
Hyb according to the manufacturer’s protocol. Membranes
were washed twice in 2 SSC (150 mM NaCl, 15 mM Na-
citrate, pH 7) at 42 jC, twice with 0.1 SSC, 0.1% SDS at
65 jC, and twice with 0.1 SSC at room temperature. As a
hybridization probe, an 880-bp fragment was cut from the
BHMT clone pMF1.103 by digestion with BglII and labeled
with [32P]-dCTP, using a random primed labeling kit
(United States Biological). Membranes were first hybridized
with the probe of interest, stripped, and then reprobed for
glyceraldehyde-3-phoshpate dehydrogenase (GAPDH) as
internal standard. Hybridization signals were detected with
a Molecular Dynamics Storm 840 Storage Phosphor Imager
with BMHT signals normalized for GAPDH expression.
Unpaired Student’s t tests were performed with StatView 4.1
from SAS Institute, Inc. (Carey, NC). Conventional North-
ern blots were exposed to Fuji RX Film with enhancer
screens and quantified by densitometric scanning with a
BioRad Model 620 densitometer.
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Fifty micrograms of rat liver homogenates was loaded
onto a 10% SDS-polyacrylamide gel and electrophoresed
overnight. The proteins were transferred to nitrocellulose
sheets (Schleicher&Schuell, Germany) by electroblotting.
Blocking of the blots was done in 2% defatted milk-powder
in 1 phosphate buffered saline. After 1 h, a mouse
monoclonal antibody prepared against the pig enzyme
(kindly provided by Timothy Garrow) was added in a
1:3000 dilution. The blots were washed five times with
the same blocking solution. Incubation with a horse-radish
peroxidase conjugated anti-mouse IgG antibody was carried
out in 5% defatted milk-powder in 1 Tris buffered saline
with 0.1% Tween-20. Final washes included 2 with
phosphate buffered saline, 2 with Tris buffered saline
with 0.1% Tween-20, and 2 with 50 mM K-glycine, 5
mM MgCl2, pH 9. Signals were detected by adding luminol/
enhancer and stable peroxide solution (SuperSignal, Pierce)
in equal proportions, followed by exposure to Fuji RX Film.
2.8. BHMT enzyme assay
3H-labelled betaine was synthesized from 3H-dimethyl-
sulfate and DL-threonin, essentially as described [14]. Briefly,
equimolar amounts of 3H-dimethylsulfate and DL-threonin
were incubated in the presence of a 10-fold molar excess of
NaOH for 3 h at room temperature. After paper electro-
phoresis at 200V for 2 h in 0.5%NaPi, pH 12,
3H-betaine was
eluted from the strip with water. Just before use, DL-homo-
cysteine thiolactone hydrochloride (15.4 mg) was activated
with 400-Al NaOH for 5 min at room temperature and then
neutralized with 600 Al of saturated KH2PO4. Enzyme assays
contained 100 nCi of labeled and 2mMof unlabelled betaine,
5 mM homocysteine, 50 mMTris–Cl pH 7.5, and 1 mg/ml of
protein extract in a total volume of 50 Al. After 0, 15, 30, 60,
90, and 120 min of incubation at 37 jC, 5-Al samples were
M. Forestier et al. / Biochimica eFig. 1. Amino acid sequence of rat BHMT derived from the DNA sequence. Residspotted on preparative silica gel thin layer plates and devel-
oped in n-butanol/acetic acid/H2O= 30:10:10 for 90 min.
After I2-staining, the areas containing the produced
3H-
methionine were scraped off the plate and radioactivity
measured by scintillation counting.3. Results
We applied mRNA differential display, an established
technique for the detection of changes in gene expression
[1,15], to the BDL rat model of liver cirrhosis. Whole rat
livers, obtained 28 days after BDL, were chosen as the
source for total RNA to ensure that changes occurring in
minor cell populations of the liver would be detected as
well. Twenty-two differential display bands unique to either
control or BDL livers (n = 4) were tested. The bands were
excised from the gels, reamplified, and used to probe
Northern blots. If a difference in signal of >50% between
control and BDL animals was observed, the PCR product
was cloned and several subclones were retested for still
displaying the expected signal on Northern blots. This step
proved to be necessary as reamplified differential display
bands often contained more than one product [2]. Six
differential display fragments were thus isolated. One frag-
ment exhibited sequence identity with the 3V-terminal cDNA
sequence of fetuin, a natural inhibitor of the insulin receptor
tyrosine kinase [16], and four bands could not be assigned to
known genes.
One differential display fragment, F18, exhibited se-
quence similarity to human BHMT. From a rat liver cDNA
library [10], clone pMF1.103 was isolated using fragment
F18 as a probe. It contained the partial coding sequence of a
protein homologous to the human BHMTenzyme (isoform 1;
a human isoform 2, BHMT2, has recently been cloned [17];
no enzyme activity could be demonstrated for BHMT2 and it
has been suggested that it could have a unique substrateues differing in human BHMT isoform 1 are indicated below the sequence.
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To obtain the 5Vsequence including the start codon that was
absent in our pMF1.103 clone, RACE was employed. The
derived amino acid sequence of rat BHMT is 92% identical to
that of human BHMT (Fig. 1) and apparently represents the
rat homologue of this enzyme [18]. Human BHMT is a zinc
protein containing three cysteine residues involved in zinc
binding [19]. These residues, C217, C299, and C300, are
strictly conserved between the rat and the human enzyme,
further supporting their homology. Although there are only
32 amino acid changes between the rat and the human
protein, they cause a change in net charge which increases
the isoelectric point by one unit, namely from 6.83 for human
BHMT to 7.88 for the rat enzyme. The significance of this
difference remains unclear.
Expression of the rat BHMT gene was assessed by North-
ern blotting (Fig. 2). It was found that BHMT mRNA wasFig. 2. Betaine homocysteine methyltransferase expression in the rat liver.
mRNA levels were detected by Northern blotting of 10 Ag of total liver
RNA from control (Ctr) and BDL induced cirrhotic rats (BDL).
Radiolabeled differential display fragment F18 was used as the probe.
(A) Representative Northern blot with two independent total RNA
preparations each, of livers from control animals, and from 28-day BDL
rats, respectively. The arrow indicates the position of the band correspond-
ing to BHMT mRNA. (B) Quantification of BHMT on Northern blots of
control and BDL rat liver at 7, 14, and 28 days after ligation. *P < 0.05
relative to 28-day controls (by Student’s t test).
Fig. 3. Betaine homocysteine methyltransferase protein levels in normal and
cirrhotic rat liver. BHMT enzyme was immunodetected on Western blots
loaded with 50 Ag of liver homogenate from control (Ctr) and BDL induced
cirrhotic animals at 28 days (BDL). The arrow indicates the position of the
band corresponding to rat BHMT at approximately 43 kDa. The migration
of protein molecular weight markers is indicated by the kDa scale in the
figure.reduced to 51F 37% 7 days after BDL, compared to controls.
Levels of BHMT mRNA continued to decline, reaching a
level of 29F 23% of controls at 28 days. To determine
whether BHMT protein levels were concomitantly reduced,
liver homogenates from normal and cirrhotic rats were
analyzed by Western blotting with a mouse monoclonal
antibody raised against pig liver BHMT and cross-reacting
with the rat enzyme [20]. The 45-kDa rat BHMT could be
detected in liver homogenates of control animals as a cross-
reacting band of the expected electrophoretic mobility, but
was undetectable in liver homogenates fromBDL rats (Fig. 3;
bands in the 50–70 kDa range were due to endogenous
peroxidase activity, while the band at 32 kDa was due to a
nonspecific cross-reaction of the antibody). Reduced BHMT
mRNA levels were thus paralleled by reduced protein levels.
To corroborate the reduced enzymes levels, BHMT activ-
ities were determined in liver homogenates using 3H-betaine
as a methyl donor and measuring the formation of radio-
labeled methionine. The activity of 0.5F 0.2 nmol/min/mg
(n = 3, F S.D.) we detected in normal rat liver homogenates
was comparable to the activity reported for porcine liver of
1.5 nmol/min/mg [6]. In cirrhotic liver tissues of 28-day BDL
rats, the BHMT activity was reduced to 0.13F 0.03 nmol/
min/mg or 26F 6% (n = 3, F S.D.). This is in good agree-
ment with the reduction of mRNA to 29F 23% in 28 day
BDL rats (n = 3, F S.D.; Fig. 2B) and, qualitatively, the
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together, our data show that (i) rats possess a BHMT enzyme
highly homologous to that of humans, and (ii) that BHMT
expression and activity are reduced to one third of normal in
rat liver cirrhosis. This is the first direct assessment of BHMT
enzyme activity in a rodent model of liver cirrhosis.4. Discussion
The alteration of the methionine metabolism in liver
cirrhosis, either in humans or in experimental animals, is
well known. Ethanol and CCl4-induced liver injury in
animals leads to reduced hepatic S-adenosylmethionine,
increased S-adenosyl-L-homocysteine, overall hepatic
DNA hypomethylation, reduced hepatic GSH content, and
increased serum homocysteine [21–23]. In human liver
cirrhosis of different origin, it has also been shown that
methionine and homocysteine levels are elevated [24,25].
The importance of these changes in the progression of the
disease has been underlined by studies showing in a variety
of animal models that the administration of S-adenosylme-
thionine reduces liver damage [26–31]. Examination of
expression levels in human liver cirrhosis recently revealed
a reduction in mRNA for several enzymes of the methionine
cycle, including methionine adenosyltransferase, glycine-N-
methyltransferase, methionine synthase, cystathione h-syn-
thase, and BHMT (cf. Fig. 4; Ref. [32]). Our knowledge on
how changes in mRNA expression are mirrored by changes
in enzyme activity and how these in turn affect metabolism
in liver cirrhosis is still very fragmentary.Fig. 4. Liver methionine cycle. BHMT, betaine homocysteine methyltransferase; C
methionine adenosyltransferase; MS, methionine synthase; MTs, methyltransfer
hydrolase; SAM, S-adenosyl methionine; THF, tetrahydrofolate; X, acceptor; X-CWe here cloned rat BHMT, an enzyme 92% identical in
amino acid sequence to human BHMT, and thus most likely
fulfilling the same biochemical role. We showed that BHMT
mRNA, protein, and activity levels were reduced substan-
tially in cirrhotic rat livers compared to controls. This
relative BHMT deficiency, together with the reported reduc-
tion of methionine synthase mRNA (which most likely
results in reduced activity of this enzyme; Ref. [32]), would
explain the increased homocysteine levels in liver cirrhosis.
Elevated homocysteine has been recognized as a risk factor
in the development of cardiovascular disease [33] and has
tentatively been explained by incorporation of homocys-
teine into proteins via its thiolactone form by an aberrant
editing process of an aminoacyl-tRNA synthetase [34].
More recently, it was shown that homocysteine directly
induces the expression of procollagen type I and tissue
inhibitor of metalloproteinases-1 genes in hepatocytes and
stellate cells in vitro [35]. This suggests that homocysteine
may be an effective inducer of liver fibrogenesis. Elevated
homocysteine levels would presumably also affect S-adeno-
sylmethionine-dependent methylation reactions, as these are
strongly inhibited by S-adenosylhomocysteine, the direct
metabolite of S-adenosylmethionine and a precursor of
homocysteine (Fig. 4). Increased levels of S-adenosylhomo-
cysteine together with a reduced S-adenosylmethionine level
are descriptive of rats fed a choline-deficient diet; this may
also hold true for cirrhosis in the bile duct ligated rat. In
essence, the cloning of rat BHMT and the demonstration of
reduced enzyme activity described here put one aspect of
the altered methionine metabolism in rat liver cirrhosis on
firm grounds.BS, cystathionine h-synthase; GNMT, glycine-N-methyltransferase; MAT,
ases; SAH, S-adenosyl homocysteine, SAHH, S-adenosyl-L-homocysteine
H3, methylated acceptor.
M. Forestier et al. / Biochimica et Biophysica Acta 1638 (2003) 29–3434Acknowledgements
We thank Bruno Hagenbuch, University of Zurich, for
providing the rat cDNA library and Timothy Garrow,
University of Illinois, for sharing BHMT antibodies with us.
This investigation was supported by Grants 31-68075.02
and 32-63476.00 from the Swiss National Foundation and a
Grant from the Wolfermann-Na¨geli-Stiftung.References
[1] P. Liang, L. Averboukh, K. Keyomarsi, R. Sager, A.B. Pardee, Differ-
ential display and cloning of messenger RNAs from human breast
cancer versus mammary epithelial cells, Cancer Res. 52 (1992)
6966–6968.
[2] M. Forestier, J. Reichen, M. Solioz, Application of mRNA differential
display to liver cirrhosis: reduced fetuin expression in biliary cirrhosis
in the rat, Biochem. Biophys. Res. Commun. 225 (1996) 377–383.
[3] L. Landmann, Cholestasis-induced alterations of the trans- and para-
cellular pathways in rat hepatocytes, Histochem. Cell Biol. 103 (1995)
3–9.
[4] S. Wasser, C.E. Tan, Experimental models of hepatic fibrosis in the
rat, Ann. Acad. Med. Singap. 28 (1999) 109–111.
[5] C. Bingham, D. Roberts, T.C. Hamilton, The role of molecular biol-
ogy in understanding ovarian cancer initiation and progression, Int. J.
Gynecol. Cancer 11 (Suppl. 1) (2001) 7–11.
[6] T.A. Garrow, Purification, kinetic properties, and cDNA cloning of
mammalian betaine-homocysteine methyltransferase, J. Biol. Chem.
271 (1996) 22831–22838.
[7] J. Kountouras, B.H. Billing, P.J. Scheuer, Prolonged bile duct obstruc-
tion: a new experimental model for cirrhosis in the rat, Br. J. Exp.
Pathol. 65 (1984) 305–311.
[8] J.B. Gross Jr., J. Reichen, T.B. Zeltner, A. Zimmermann, The evolu-
tion of changes in quantitative liver function tests in a rat model of
biliary cirrhosis: correlation with morphometric measurement of hep-
atocyte mass, Hepatology 7 (1987) 457–463.
[9] P. Chomczynski, N. Sacchi, Single-step method of RNA isolation by
acid guanidinum thiocyanate-phenol-chloroform extraction, Anal. Bi-
ochem. 162 (1987) 156–159.
[10] M. Bissig, B. Hagenbuch, B. Stieger, T. Koller, P.J. Meier, Functional
expression cloning of the canalicular sulfate transport system of rat
hepatocytes, J. Biol. Chem. 269 (1994) 3017–3021.
[11] R.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.A. Smith, K.
Struhl, Current Protocols in Molecular Biology, Wiley, New York,
1995.
[12] J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular Cloning, Cold
Spring Harbor Laboratory Press, Cold Spring Harbor, 1989.
[13] N.R. Rave, X. Crkvenjakov, H. Boedtker, Identification of procolla-
gen mRNAs transferred to diazobenzyloxmethyl paper form formal-
dehyde agarose gels, Nucleic Acids Res. 6 (1979) 3559.
[14] H.D. Dakin, The formation of betaine from hydroxyamino acids on
methylation, J. Biol. Chem. 140 (1941) 847–852.
[15] P. Liang, A.B. Pardee, Differential display of eukaryotic messenger
RNA by means of the polymerase chain reaction, Science 257 (1992)
967–971.
[16] P. Auberger, L. Falquerho, J.O. Contreres, G. Pages, G. Le Cam, B.
Rossi, A. Le Cam, Characterization of a natural inhibitor of the in-
sulin receptor tyrosine kinase: cDNA cloning, purification, and anti-
mitogenic activity, Cell 58 (1989) 631–640.
[17] L.H. Chadwick, S.E. McCandless, G.L. Silverman, S. Schwartz, D.
Westaway, J.H. Nadeau, Betaine-homocysteine methyltransferase-2:
cDNA cloning, gene sequence, physical mapping, and expression of
the human and mouse genes, Genomics 70 (2000) 66–73.[18] M.P. Sowden, H.L. Collins, H.C. Smith, T.A. Garrow, J.D. Sparks,
C.E. Sparks, Apolipoprotein B mRNA and lipoprotein secretion are
increased in McArdle RH-7777 cells by expression of betaine-homo-
cysteine S-methyltransferase, Biochem. J. 341 (Pt 3) (1999) 639–645.
[19] N.S. Millian, T.A. Garrow, Human betaine-homocysteine methyl-
transferase is a zinc metalloenzyme, Arch. Biochem. Biophys. 356
(1998) 93–98.
[20] S.L.F. Sunden, M.S. Renduchintala, E.I. Park, S.D. Miklasz, T.A.
Garrow, Betaine-homocysteine methyltransferase expression in por-
cine and human tissues and chromosomal localization of the human
gene, Arch. Biochem. Biophys. 345 (1997) 171–174.
[21] G. Varela-Moreiras, E. Alonso-Aperte, M. Rubio, M. Gasso, R.
Deulofeu, L. Alvarez, J. Caballeria, J. Rodes, J.M. Mato, Carbon
tetrachloride-induced hepatic injury is associated with global DNA
hypomethylation and homocysteinemia: effect of S-adenosylmethio-
nine treatment, Hepatology 22 (1995) 1310–1315.
[22] K.C. Trimble, A.M. Molloy, J.M. Scott, D.G. Weir, The effect of
ethanol on one-carbon metabolism: increased methionine catabolism
and lipotrope methyl-group wastage, Hepatology 18 (1993) 984–989.
[23] A.J. Barak, H.C. Beckenhauer, D.J. Tuma, Betaine, ethanol, and the
liver: a review, Alcohol 13 (1996) 395–398.
[24] A. Bosy-Westphal, S. Petersen, H. Hinrichsen, N. Czech, J. Muller,
Increased plasma homocysteine in liver cirrhosis, Hepatol. Res. 20
(2001) 28–38.
[25] E.R. Garcia-Tevijano, C. Berasain, J.A. Rodriguez, F.J. Corrales, R.
Arias, A. Martin-Duce, J. Caballeria, J.M. Mato, M.A. Avila, Hyper-
homocysteinemia in liver cirrhosis: mechanisms and role in vascular
and hepatic fibrosis, Hypertension 38 (2001) 1217–1221.
[26] C.S. Lieber, A. Casini, L.M. DeCarli, C.I. Kim, N. Lowe, R. Sasaki,
M.A. Leo, S-adenosyl-L-methionine attenuates alcohol-induced liver
injury in the baboon, Hepatology 11 (1990) 165–172.
[27] F. Corrales, A. Gimenez, L. Alvarez, J. Caballeria, M.A. Pajares, H.
Andreu, A. Pares, J.M. Mato, J. Rodes, S-adenosylmethionine treat-
ment prevents carbon tetrachloride-induced S-adenosylmethionine syn-
thetase inactivation and attenuates liver injury, Hepatology 16 (1992)
1022–1027.
[28] C. Garcia-Ruiz, A. Morales, A. Colell, A. Ballesta, J. Rodes, N.
Kaplowitz, J.C. Fernandez-Checa, Feeding S-adenosyl-L-methionine
attenuates both ethanol-induced depletion of mitochondrial gluta-
thione and mitochondrial dysfunction in periportal and perivenous
rat hepatocytes, Hepatology 21 (1995) 207–214.
[29] G.P. Bray, J.M. Tredger, R. Williams, S-adenosylmethionine protects
against acetaminophen hepatotoxicity in two mouse models, Hepatol-
ogy 15 (1992) 297–301.
[30] R.M. Pascale, V. Marras, M.M. Simile, L. Daino, G. Pinna, S. Bennati,
M. Carta, M.A. Seddaiu, G. Massarelli, F. Feo, Chemoprevention of rat
liver carcinogenesis by S-adenosyl-L-methionine: a long-term study,
Cancer Res. 52 (1992) 4979–4986.
[31] R.K. Chawla, H.L. Bonkovsky, J.T. Galambos, Biochemistry and
pharmacology of S-adenosyl-L-methionine and rationale for its use
in liver disease, Drugs 40 (Suppl. 3) (1990) 98–110.
[32] M.A. Avila, C. Berasain, L. Torres, A. Martin-Duce, F.J. Corrales, H.
Yang, J. Prieto, S.C. Lu, J. Caballeria, J. Rodes, J.M. Mato, Reduced
mRNA abundance of the main enzymes involved in methionine me-
tabolism in human liver cirrhosis and hepatocellular carcinoma, J.
Hepatol. 33 (2000) 907–914.
[33] M.R. Malinow, Plasma homocyst(e)ine and arterial occlusive dis-
eases: a mini-review, Clin. Chem. 41 (1995) 173–176.
[34] H. Jakubowski, Metabolism of homocysteine thiolactone in human
cell cultures. Possible mechanism for pathological consequences of
elevated homocysteine levels, J. Biol. Chem. 272 (1997) 1935–1942.
[35] L. Torres, E.R. Garcia-Trevijano, J.A. Rodriguez, M.V. Carretero, M.
Bustos, E. Fernandez, E. Eguinoa, J.M. Mato, M.A. Avila, Induction
of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: a
new role for homocysteine in liver fibrosis, Biochim. Biophys. Acta
1455 (1999) 12–22.
